Concepedia

Phase II Trial of Loubo<sup>®</sup>(Lobaplatin) and Pemetrexed for Patients with Metastatic Breast Cancer not Responding to Anthracycline or Taxanes

Qianqian Deng, Xin‐En Huang, Lihong Ye, Yan-Yan Lu, Yong Liang, Jin Xiang

Asian Pacific Journal of Cancer Prevention · 2013 · 62 citations · 27 references

DOIFull text

Open access

Abstract

The regimen of lobaplatin and pemetrexed is modestly active in metastatic breast cancer patients who failed anthracycline or taxanes, and the toxicity profile suggesting that the doses of chemotherapy should be further modified.

References

27

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

Gianni Bonadonna, Ercole Brusamolino, Pinuccia Valagussa et al. · New England Journal of Medicine · 1976 · 1.3K citations

Adjuvant Docetaxel for Node-Positive Breast Cancer

Miguel Martín, Tadeusz Pieńkowski, John R. Mackey et al. · New England Journal of Medicine · 2005 · 950 citations · Full text

Inhibition of Tumor Growth in Vitro by a Combination of Extracts from Rosa Roxburghii Tratt and Fagopyrum Cymosum

Wei Liu, Suyi Li, Xin‐En Huang et al. · Asian Pacific Journal of Cancer Prevention · 2012 · 74 citations · Full text

Comparison of Complications of Peripherally Inserted Central Catheters with Ultrasound Guidance or Conventional Methods in Cancer Patients

Ping Gong, Xin‐En Huang, Chuan-Ying Chen et al. · Asian Pacific Journal of Cancer Prevention · 2012 · 63 citations · Full text

MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy.

Ying Li, Pengwei Yan, Xin‐En Huang et al. · PubMed · 2011 · 59 citations